High resolution magnetic resonance imaging of the brain in the dy/dy mouse with merosin-deficient congenital muscular dystrophy

Neuromuscular Disorders

Volumn 10, Issue 4-5, 2000, Pages 292-298

  Dubowitz, David J ^a,d   Michael Tyszka, J ^a,b   Sewry, Caroline A ^b,d   Moats, Rex A ^b,c   Scadeng, Miriam ^a,b   Dubowitz, Victor ^a,b  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c London School of Tropical Medicine   (United Kingdom)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Congenital muscular dystrophy; Dy dy mouse; Laminin 2; Magnetic resonance imaging; Merosin

Indexed keywords

LAMININ; MEROSIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; MUSCULAR DYSTROPHY; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT; LAMININ; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCULAR DYSTROPHIES;

EID: 0034213287     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(00)00104-8     Document Type: Article

References (32)

1. Dubowitz V. 22nd ENMC sponsored workshop on congenital muscular dystrophy Baarn The Netherlands. Neuromusc Disord 1994;4:75-81.
2. Tome FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. CR Acad Sci Paris, Life Sci 1994;317:351-357.
3. Dubowitz V. 41st ENMC International workshop on congenital muscular dystrophy. Neuromusc Disord 1996;6:295-306.
4. Hillaire D, Leclerc A, Faure S, et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994;3:1657-1661.
5. Guicheney P, Vignier N, Zhang X, et al. PCR based mutation screening of the laminin alpha 2 chain gene (LAMA2): application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy. J Med Genet. 1998;35:211-217.
6. Echenne B, Arthuis M, Billard C, et al. Congenital muscular dystrophy and cerebral CT scan anomalies Results of a collaborative study of the Societe de Neurologie Infantile. J Neurol Sci 1986;75:7-22.
7. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-305.
8. Mercuri E, Pennock J, Goodwin F, et al. Sequential study of central and peripheral nervous system involvement in an infant with merosindeficient congenital muscular dystrophy. Neuromusc Disord. 1996;6:425-429.
9. van der Knaap MS, Valk J. Congenital muscular dystrophy. In: Magnetic resonance of myelin, myelinatton, and myelin disorders, 2nd 1995:267-276.
10. Arahata K, Hayashi YK, Koga R, et al. Laminin in animal models for muscular dystrophy: defect of laminin M in skeletal and cardiac muscles and peripheral nerve of homozygous dystrophic dy/dy mice. Proc Jpn Acad. 1993;69:259-264.
11. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic-linkage of laminin m-chain gene to dy locus. J Biol Chem. 1994;269:13729-13732.
12. Shorer Z, Philpot J, Muntoni F, et al. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J Child Neurol 1995; 10:472-475.
13. Bradley WG, Jenkison M. Neural abnormalities in the dystrophic mouse. J Neurol Sci 1975;25:249-255.
14. Matsumura C, Yamada H, Saito F, et al. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromusc Disord 1997;7:7-12 (Review).
15. Michelson AM, Russell ES, Harman PJ. Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc Natl Acad Sci USA 1955;41:1079-1084.
16. Cremillieux Y, Ding S, Dunn JF. High-resolution in vivo measurements of transverse relaxation times in rats at 7 Tesla. Magn Reson Med 1998;39:285-290.
17. Chen JH, Avram HE, Crooks LE, Arakawa M, Kaufman L, Brito AC. In vivo relaxation times and hydrogen density at 0.063-4.85 T in rats with implanted mammary adenocarcinomas. Radiology 1992;184:427-434.
18. Hoehn-Berlage M, Eis M, Back T, Kohno K, Yamashita K. Changes of relaxation times (Tl T2) and apparent diffusion coefficient after permanent middle cerebral artery occlusion in the rat: temporal evolution regional extent, and comparison with histology. Magn Reson Med 1995;34:824-834.
19. Hennig J, Nauerth A, Friedburg H. Rare Imaging - A fast imaging method for clinical MR. Mag Reson Med 1986(3):823-833.
20. Shinnar M, Bolinger L, Leigh JS. The synthesis of soft pulses with a specified frequency response. Magn Reson Med 1989; 12:88-92.
21. Pauly J, Le Roux P, Nishimura D, Macovski A. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm. IEEE Trans Med Imag 1991; 10:53-65.
22. Sewry CA, Uziyel Y, Torelli S, et al. Differential labelling of laminin α2 in muscle and neural tissue of dy/dy mice; are there isoforms of the laminin α2 chain? Neuropath Appl Neurobiol 1998;24:66-72 (erratum p. 166).
23. Tan F, Topaloglu H, Sewry C, et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromusc Disord 1997;7:85-89.
24. Dubowitz V. 68th ENMC International Workshop (5th International Workshop) on congenital muscular dystrophy, Naarden, The Netherlands. Neuromusc Disord 1999;9:446-454.
25. Blumich B, Kuhn W, editors. Magnetic resonance microscopy: Methods and applications in material science, agriculture and biomedicine Wiley-VCH Publishers, 1992.
26. Jacobs RE, Fraser SE. Imaging neuronal development with magnetic resonance imaging (NMR) microscopy. J Neurosci Methods 1994;54:189-196.
27. Dockery SE, Suddarth SA, Johnson GA. Relaxation measurements at 300 MHz using MR microscopy. Magn Reson Med 1989;11:182-192.
28. Cohn RD, Herrmann R, Wewer UM, Voit T. Changes of laminin beta 2 chain expression in congenital muscular dystrophy. Neuromusc Disord 1997;7:373-378.
29. Ringelmann B, Roder C, Hallmann R, et al. Expression of laminin α1, α2, α4, and α5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice. Exp Cell Res 1999;246:165-182.
30. Hagg T, Portera-Cailliau C, Jucker M, Engvall E. Laminins of the adult mammalian CNS; laminin-alpha2 (merosin M-) chain immunoreactivity is associated with neuronal processes. Brain Res 1997;764:17-27.
31. Villanova M, Sewry CA, Malandrini A, et al. Localisation of several laminin chains in the normal human central and peripheral nervous system. J Submicrosc Cytol Pathol 1997;29:409-413.
32. Villanova M, Malandrini A, Sabatelli P, et al. Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta Neuropathol 1997;94:567-571.